PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Need help narrowing down your IDWeek re-watch content? Or maybe you were unable to make IDWeek so you want the pharmacy driven highlights? Well, look no further, Breakpoints has what you need!
Join your Breakpoints hosts, Drs. Erin McCreary (@ErinMcCreary), Julie Ann Justo (@julie_justo), and Jeannette Bouchard (@jlbouchard001) for a review of some of the late breaking clinical trials presented at IDWeek 2023.
References:
- Oral Fosfomycin vs IV BL/BLI/Carbapenem in cUTI: doi:10.1093/ofid/ofad500.002
- Oral Fosfomycin for male UTIs: doi:10.3390/antibiotics11020198 and prostatitis: doi:10.1093/jac/dkz015
- ATM-AVI for cIAIA or HAP/VAP (REVISIT): doi:10.1093/ofid/ofad500.2476
- CAZ-AVI for neonates: doi:10.1093/ofid/ofad500.2473
- ACORN RCT: doi:10.1001/jama.2023.20583
- HARMONIE RCT: doi:10.1093/ofid/ofad500.005
Julie Ann Justo, PharmD, MS, FIDSA, BCPS-AQ ID
Dr. Julie Ann Justo is a Clinical Pharmacist Lead of Infectious Diseases at Dartmouth-Hitchcock Medical Center.
Jeannette Bouchard PharmD, BCIDP
Dr. Jeannette Bouchard is a clinical pharmacist liaison at DASON. (And at this time chair of our Breakpoints committee.)
